| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.11 | 0.05 |